Financials data is unavailable for this security.
View more
Year on year Twist Bioscience Corp grew revenues 27.69% from 245.11m to 312.97m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -204.62m to -208.73m.
Gross margin | 42.61% |
---|---|
Net profit margin | -66.69% |
Operating margin | -70.56% |
Return on assets | -30.02% |
---|---|
Return on equity | -38.08% |
Return on investment | -33.49% |
More ▼
Cash flow in USDView more
In 2024, cash reserves at Twist Bioscience Corp fell by 60.15m. Cash Flow from Financing totalled 6.89m or 2.20% of revenues. In addition the company used 64.09m for operations while cash used for investing totalled 3.07m.
Cash flow per share | -3.06 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 8.03 |
---|---|
Tangible book value per share | 6.33 |
More ▼
Balance sheet in USDView more
Current ratio | 4.88 |
---|---|
Quick ratio | 4.54 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼